Keyphrases
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
100%
Prognostic Factors
100%
Urokinase-type Plasminogen Activator
100%
Invasive Cancer Cell
100%
Distal Gastric Adenocarcinoma
100%
Cancer Cells
42%
Overall Survival
28%
Gastric Cancer
28%
Gastric Cancer Patients
28%
Immunohistochemistry
14%
Multivariate Analysis
14%
Malignancy
14%
Tissue Sampling
14%
Univariate Analysis
14%
Tumor Cells
14%
Macrophages
14%
Immunoreactivity
14%
Poor Prognosis
14%
Prognostic Significance
14%
Neutrophils
14%
In Cancer
14%
Plasminogen Activation
14%
Extracellular Matrix Degradation
14%
Independent Prognostic Factor
14%
5-year Survival
14%
TNM Staging
14%
Micrometastasis
14%
Neoplastic Cells
14%
Cell Surface
14%
Myofibroblast
14%
Histological Subtypes
14%
Gastric Cancer Cells
14%
Second Cancer
14%
Causing Death
14%
Intestinal Type
14%
Diffuse Type
14%
Cell Subtypes
14%
Invasive Front
14%
Invasion Zone
14%
Invasive Potential
14%
Gastric Adenocarcinoma
14%
Medicine and Dentistry
Prognostic Factor
100%
Tumor Invasion
100%
Urokinase
100%
Urokinase Receptor
100%
Cancer Cell
100%
Stomach Adenocarcinoma
100%
Stomach Cancer
71%
Overall Survival
28%
Disease
14%
Multivariate Analysis
14%
Cancer
14%
Univariate Analysis
14%
Tumor Cell
14%
Receptor
14%
Immunohistochemistry
14%
Extracellular Matrix
14%
Macrophage
14%
Immunoreactivity
14%
Plasminogen Activation
14%
Neutrophil
14%
Micrometastasis
14%
Cell Surface
14%
Second Cancer
14%
Myofibroblast
14%
Pharmacology, Toxicology and Pharmaceutical Science
Urokinase Receptor
100%
Urokinase
100%
Tumor Invasion
100%
Stomach Adenocarcinoma
100%
Stomach Cancer
71%
Malignant Neoplasm
42%
Overall Survival
28%
Disease
14%
Receptor
14%
Neoplasm
14%
Plasminogen
14%
Second Cancer
14%
Micrometastasis
14%
Biochemistry, Genetics and Molecular Biology
Urokinase Receptor
100%
Cancer Cell
100%
Urokinase
100%
Overall Survival
28%
Eicosanoid Receptor
14%
Macrophage
14%
Immunoreactivity
14%
Surface Property
14%
Multivariate Analysis
14%
Neutrophil Granulocyte
14%
Plasminogen Activation
14%
Myofibroblast
14%